Search clinical trials for: Moxifloxacin and Cobicistat

Total 272550 results

National Institute of Allergy and Infectious Diseases...
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum

HIV Infections | Tuberculosis

United States, Malawi, Puerto Rico, South Africa, Thailand, Zimbabwe, Brazil, Kenya, Uganda, India, Tanzania, Botswana
Aziende Chimiche Riunite Angelini Francesco S.p.A
Cross Research S.A.; eResearch Technology, Inc.

Completed

Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy Volunteers

Healthy

Switzerland
Janssen Research & Development, LLC

Completed

A Study to Evaluate the Effects of JNJ-54861911 on Electrocardiogram Intervals in Healthy Particiants

Healthy

United States
Centers for Disease Control and Prevention
AIDS Clinical Trials Group

Completed

TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens (S31/A5349)

Tuberculosis

United States, Brazil, China, Haiti, India, Kenya, Malawi, Peru, South Africa, Thailand, Uganda, Vietnam, Zimbabwe
Technical University of Munich
Gilead Sciences; MUC Research GmbH

Completed

Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication

Insulin Resistance

Germany
Bp Consulting, Inc

Completed

Determination of Optimum Duration of Treatment With Bromfenac (Xibrom) Eyedrops Following Cataract Surgery

Cataracts

United States
St Stephens Aids Trust
Bristol-Myers Squibb

Terminated

Pharmacokinetic Effect of Evotaz/Microgynon Co-administration

HIV

United Kingdom
Johns Hopkins University

Terminated

Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine

Mycobacterium Tuberculosis

United States
GlaxoSmithKline

Withdrawn

A Study to Evaluate the Effect of GSK1322322 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers

Infections, Bacterial
Chiesi Farmaceutici S.p.A.

Completed

Evaluation of Possible Effects on the QTc Interval of CHF 4226 pMDI in Healthy Volunteers (CT14)

Chronic Obstructive Pulmonary Disease

United States
Gilead Sciences

Completed

Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults

HIV Infections | HIV

United States
Pfizer

Completed

A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and Moxifloxacin

Healthy Volunteers

Belgium
Boehringer Ingelheim

Completed

Electrophysiological Effects of Tipranavir Co-administered With Ritonavir on the QT Interval in Healthy Female and Male Subjects

Healthy
Bristol-Myers Squibb

Completed

Study to Determine the Effect of BMS-791325 on the ECG QTcF Interval in Healthy Subjects

Hepatitis C

United States
Bristol-Myers Squibb

Completed

Taste Properties of Atazanavir and Cobicistat

HIV in Adults

United States
Sun Yat-sen University

Recruiting

Moxifloxacin in Adjuvant Treatment of Patients With Operable Breast Cancer

Breast Cancer

China
Trevena Inc.

Completed

Study of the Effects of TRV130, at Therapeutic and Supra Therapeutic Doses, on QTc Intervals

Healthy

United States
Alexza Pharmaceuticals, Inc.

Completed

Staccato Prochlorperazine Thorough QT/QTc

Cardiotoxicity

United States
Kenneth H. Mayer, MD
Gilead Sciences

Completed

HIV Non-Occupational Post-Exposure Prophylaxis (QUAD)

Human Immunodeficiency Virus

United States
Kaohsiung Veterans General Hospital.
Chang Gung Memorial Hospital; Taipei Veterans General Hospital, Taiwan; National... and other collaborators

Not yet recruiting

Evaluation of the Efficacy and Safety of a 4-month Daily Regimen (2HZPM/2HPM) for Treatment of Pulmonary TB (ESCAPE-TB)

Tuberculosis, Pulmonary

Taiwan
Boehringer Ingelheim

Completed

Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers

Healthy
Forest Laboratories

Completed

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Schizophrenia

United States
AstraZeneca

Completed

A Study to Investigate the Effect on QTcF of Baxdrostat Compared With Placebo, Using Moxifloxacin as a Positive Control, in Healthy Participants

Healthy Participants

Germany
Cytokinetics

Completed

Study to Assess the Effect of Omecamtiv Mecarbil (OM) on QT/QTc Intervals in Healthy Adults

QT Intervals Changes | QTc Intervals Changes

United Kingdom
Richmond Research Institute
Richmond Pharmacology Limited

Completed

Effect of Glucose on QTc Interval in Type 1 Diabetes

Diabetes

United Kingdom
Frank A. Bucci, Jr., M.D.

Completed

Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification

Cataracts

United States
Bristol-Myers Squibb

Completed

An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects

Systemic Lupus Erythematosus | Healthy Participants

United States
Melinta Therapeutics, Inc.

Completed

Efficacy and Safety Study of Oral Solithromycin (CEM-101) Compared to Oral Moxifloxacin in Treatment of Patients With Community-Acquired Bacterial Pneumonia (SOLITAIRE-ORAL)

Community-acquired Bacterial Pneumonia

Spain, United States, Hungary, Canada, Estonia, Russian Federation, Argentina, Bulgaria, Czech Republic, Dominican Republic, Ecuador, Germany, Latvia, Poland, Puerto Rico, Romania, South Africa
Kowa Research Institute, Inc.

Completed

A Thorough Corrected QT Interval Trial

Dyslipidemia

United States
Research Insight LLC

Completed

A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1%

Cataract

United States
Ophthalmic Consultants of Long Island
Ocular Therapeutix, Inc.

Unknown

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery (CIMPLIFY)

Patient Preference

United States
Federal University of São Paulo
Alcon Research

Completed

Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunctivitis (BRA-07-02)

Conjunctivitis | Keratitis | Blepharitis

Brazil
Bayer

Completed

Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia

Pneumonia

Belgium, Germany, Spain, Greece, France, Netherlands, Chile, Mexico, Poland, South Africa, United Kingdom, Argentina, Colombia, Israel, Lithuania, Peru, Portugal, Sweden
Eli Lilly and Company
Loxo Oncology, Inc.

Completed

A Study to Evaluate the Effect of Pirtobrutinib (LOXO-305) on QTc Interval in Healthy Participants

Healthy

United States
Corcept Therapeutics

Completed

T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers

Healthy

United States
BeiGene

Completed

A Two-Part Phase 1 Study to Investigate the Safety and Tolerability of Supratherapeutic Dose of Zanubrutinib and Effect of Zanubrutinib on Cardiac Repolarization in Healthy Subjects

Healthy Volunteers

United States
Da Volterra

Completed

Safety and Efficacy Study of Different DAV132 Dose Regimens in Healthy Volunteers

Healthy Subjects

France
Samsung Medical Center
H. Lundbeck A/S

Completed

Changes of Cerebral Glucose Metabolism and After 12 Weeks of Escitalpram Treatment in Panic Disorder

Panic Disorder

Korea, Republic of
Mast Therapeutics, Inc.

Completed

ANX-188 Thorough QT/QTc Study in Healthy Volunteers

Healthy

United States
Achieve Life Sciences

Completed

Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers

Smoking Cessation

Portugal
UCB Biopharma S.P.R.L.

Terminated

A Study to Test the Cardiac Effects of Padsevonil in Healthy Study Participants

Healthy Study Participants

United Kingdom
Melinta Therapeutics, Inc.

Completed

Study to Compare Delafloxacin to Moxifloxacin for the Treatment of Adults With Community-acquired Bacterial Pneumonia (DEFINE-CABP)

Community Acquired Bacterial Pneumonia

United States, Argentina, Bulgaria, Colombia, Dominican Republic, Georgia, Germany, Hungary, Latvia, Peru, Poland, Romania, Russian Federation, Serbia, Slovenia, South Africa, Spain, Ukraine
Allergan
MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan

Completed

QT Intervals Study to Compare the Acute Effects of Orally Inhaled Dihydroergotamine (DHE), Oral Moxifloxacin, and Placebo

Healthy

United States
Kocaeli University

Completed

Alternative Antibiotic Regime in the Treatment of GAgP

Aggressive Periodontitis | Generalized Aggressive Periodontitis

Turkey
Achieve Life Sciences
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

Thorough QT/QTc (Corrected QT Interval) Study to Evaluate the Effect of Custirsen on Cardiac Repolarization

Cardiac Conduction and Repolarization

United States
Vantia Ltd

Completed

A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval

Healthy

Germany
Alkermes, Inc.

Completed

A Study to Evaluate the Effect of ALKS 5461 on QT Intervals in Healthy Volunteers

Healthy

United States
University College, London
University of Cambridge; National Institute for Health Research, United Kingdom and other collaborators

Unknown

Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD).

United Kingdom
Bausch & Lomb Incorporated

Completed

Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical Instillation

Healthy

United States
Fred Hutchinson Cancer Center
National Institute on Drug Abuse (NIDA); Asociación Civil Impacta Salud y Educación... and other collaborators

Completed

HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women (SABES?)

HIV

Peru

Search clinical trials for: Moxifloxacin and Cobicistat

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations